Skip to main content
Caplight Logo









ViewsML

ViewsML

Private
VancouverHealthcare & Life Scienceshttps://www.viewsml.com/

Last Round

Seed

Apr 20, 2026

Total Funding Raised

$3.54M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

ViewsML is a healthcare IT company that has developed an AI-powered platform and virtual biomarker library to generate per-cell biomarker spatial insights from standard pathology images, eliminating the need for physical laboratory staining.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Drug Discovery, Precision Medicine, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

virtual stainingvirtual immunohistochemistryvIHCcomputational pathologybiomarker analysisdigital pathologyAI diagnosticstechbiovirtual biomarkersimmunohistochemistryIHCH&E stainingdrug developmentprecision medicinequantitative pathologyclinical trial stratification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ViewsML Comparables

Compare ViewsML with similar companies based on industry and business-model similarity.

ViewsML comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pictor Labs
89%
Acurion
83%
ITsci Company Limited
77%

ViewsML Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 20, 2026
SeedApr 1, 2024

Key People

Founding team and executive leadership

Kenneth To

Chief Executive Officer

Executive Team

ViewsML Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 998% MoM, reaching 5.2K.

  • Jul 20, 2026

    Open roles increased to 4, 2.7x the trailing average.

Recent news

Latest coverage and updates

  • recognized_asJul 2, 2026

    Viewsml recognized as 2026 Companies to Watch Honour Roll at 28th Annual Life Sciences BC Awards.

ViewsML Filings

Explore SEC and related filing metadata, where available.

ViewsML filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ViewsML's valuation, stock price, and market status.

Is ViewsML a public or private company?

ViewsML is a private company.

What is the current stock price of ViewsML?

ViewsML is a private company with no public stock price. No recent secondary market data is available.

How much is ViewsML worth (valuation)?

Valuation information for ViewsML is not publicly available.

Can I buy ViewsML stock?

ViewsML shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ViewsML's last funding round?

ViewsML's most recent funding round was Seed on April 20, 2026.

Who are the main investors in ViewsML?

Key investors in ViewsML include Wittington Ventures.

Will ViewsML IPO soon?

No public IPO plans have been announced for ViewsML.

How can I track ViewsML secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ViewsML's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVancouver
Employee Range12
Year Founded2022
Last FundingApr 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?